GA
General Atlantic’s Royalty Pharma RPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $54M | Hold |
1,500,000
| – | – | 1.49% | 11 |
|
2025
Q1 | $46.7M | Hold |
1,500,000
| – | – | 1.57% | 9 |
|
2024
Q4 | $38.3M | Hold |
1,500,000
| – | – | 1.36% | 9 |
|
2024
Q3 | $42.4M | Hold |
1,500,000
| – | – | 1.21% | 11 |
|
2024
Q2 | $39.6M | Hold |
1,500,000
| – | – | 1.24% | 12 |
|
2024
Q1 | $45.6M | Hold |
1,500,000
| – | – | 1.06% | 14 |
|
2023
Q4 | $42.1M | Hold |
1,500,000
| – | – | 0.6% | 16 |
|
2023
Q3 | $40.7M | Hold |
1,500,000
| – | – | 0.63% | 20 |
|
2023
Q2 | $46.1M | Hold |
1,500,000
| – | – | 0.73% | 20 |
|
2023
Q1 | $54M | Hold |
1,500,000
| – | – | 0.63% | 16 |
|
2022
Q4 | $59.3M | Hold |
1,500,000
| – | – | 0.78% | 15 |
|
2022
Q3 | $60.3M | Hold |
1,500,000
| – | – | 0.71% | 16 |
|
2022
Q2 | $63.1M | Hold |
1,500,000
| – | – | 0.82% | 14 |
|
2022
Q1 | $58.4M | Hold |
1,500,000
| – | – | 0.53% | 16 |
|
2021
Q4 | $59.8M | Hold |
1,500,000
| – | – | 0.46% | 17 |
|
2021
Q3 | $54.2M | Hold |
1,500,000
| – | – | 0.32% | 17 |
|
2021
Q2 | $61.5M | Hold |
1,500,000
| – | – | 0.43% | 11 |
|
2021
Q1 | $65.4M | Hold |
1,500,000
| – | – | 0.77% | 8 |
|
2020
Q4 | $75.1M | Hold |
1,500,000
| – | – | 0.98% | 7 |
|
2020
Q3 | $63.1M | Hold |
1,500,000
| – | – | 0.97% | 5 |
|
2020
Q2 | $72.8M | Buy |
+1,500,000
| New | +$72.8M | 2.18% | 4 |
|